Where all your ID needs are met! Sort of.
What is this? I am writing about a topic related to transplant infectious diseases? Something has to be going on! I had originally intended to write about CMV serostatus and risk of organ rejection in SOT patients, but that was a more difficult topic to tackle (just like that HTLV-1 post; yeah that one is
Liao X, Wang Y, He Z, et al. Three-month pulmonary function and radiological outcomes in COVID-19 survivors: a longitudinal patient cohort study. Open Forum Infect Dis. 2020;ofaa540. Published 2020 Nov 14. doi:10.1093/ofid/ofaa540 How does pulmonary function fare following COVID infection? This retrospective study 172 patients who were hospitalized with COVID and evaluated both CT and
Primary infection with T. cruzi, also known as American trypanosomiasis, is generally asymptomatic with a small percentage having non-specific symptoms such as fever, malaise, lymphadenopathy, and in certain cases, a Chagoma. The vast majority of people go on to develop an “intermediate” form of the disease, where serology is positive but there is no sign
ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators, Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4. PMID: 34351721; PMCID: PMC8362594. A pair of articles on anticoagulation. The first one is on non-critically ill patients
Dr. Germophile 